Brief: Gen Ilac Ve Saglik Urunleri Q2 Net Loss Widens To 181.5 Million Lira YoY
Aug 28 (Reuters) - Gen Ilac ve Saglik Urunleri Sanayi ve
Ticaret AS GENIL.IS :
* GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET AS - Q2 NET
LOSS
OF 181.5 MILLION LIRA VERSUS LOSS OF 141.9 MILLION LIRA YEAR AGO
* GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET AS - Q2
REVENUE OF
3.15 BILLION LIRA VERSUS 1.98 BILLION LIRA YEAR AGO
Source text for Eikon: ID:nIKAPW63b
Further company coverage: GENIL.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira